市場調査レポート

商品コード

動物治療薬および診断薬の世界市場

Global Markets for Animal Therapeutics and Diagnostics

出版日: 2023年11月10日 | 発行: BCC Research

| ページ情報: 英文 303 Pages | 納期: 即納可能

価格

PDF & Excel (Single User License)

USD 5,500 862,180円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は、機能制限があるわけではありませんが、1回までとされます。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (2-5 Users)

USD 6,600 1,034,616円

レポートPDFおよびExcelを同一国内の5名迄にてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は計5回までとされます。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 7,920 1,241,539円

レポートPDFおよびExcelを同一事業所に所属される方にて人数に制限なく共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。印刷機能に回数制限はありませんが、印刷したもののご利用はPDFのご利用者と同一範囲内です。

PDF & Excel (Enterprise License)

USD 9,504 1,489,847円

レポートPDFおよびExcelを同一企業の全ての事業所（資本100%子会社含む）にて人数に制限なく共有ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。印刷機能に回数制限はなく、同一企業内にて配布ご利用可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の動物治療薬および診断薬の市場規模は、2023年の610億米ドルから、予測期間中は5.9%のCAGRで推移し、2028年には812億米ドルの規模に成長すると予測されています。

医薬品の部門は、2023年の246億米ドルから、同期間中6.2%のCAGRで推移し、2028年には333億米ドルの規模に成長すると予測されています。また、飼料添加剤の部門は、2023年の216億米ドルから、5.0%のCAGRで推移し、2028年には275億米ドルの規模に成長すると予測されています。

当レポートでは、世界の動物治療薬および診断薬の市場を調査し、市場の背景・概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、技術および特許の動向、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

市場力学
市場促進要因
市場抑制要因
機会
規制状況
Food and Drug Administration (FDA)
European Medicines Agency (EMA)・Committee for Medicinal Products for Veterinary Use (CVMP)
Australian Pesticides and Veterinary Medicines Authority (APVMA)
ブラジルThe Ministry of Agriculture, Livestock and Supply (MAPA)
生産動物における抗生物質の使用と耐性
FDAの抗菌制限
米国における汚染肉レベル
家畜生産における抗生物質の減量を求める運動
最小限および高度に規制された製品
2003年のAnimal Drug User Fee Act
2008年のAnimal Drug User Fee Act改正 (ADUFA II)
2013年のAnimal Drug User Fee Act改正 (ADUFA III)
2018年のAnimal Drug User Fee Act改正 (ADUFA III)

第5章世界の動物治療薬および診断薬市場

概要
市場規模

第6章世界の動物ワクチン市場

概要
製品概要
能動免疫
受動免疫
その他のタイプ
コンパニオンアニマル
ウイルス
コンパニオンアニマルのワクチン
コンパニオンアニマルワクチン市場の主要企業
ワクチン提供者
生産動物
ウイルスとプリオン
動物ワクチンの製造
生産動物ワクチン市場の主要企業

第7章世界の動物医薬品市場

概要
動物医薬品
コンパニオンアニマル市場と生産動物市場
地域別の動物医薬品市場
アレルギー薬と呼吸器薬
コンパニオンアニマル：アレルギーと炎症性疾患
動物用アレルギーおよび呼吸器薬市場の主要企業
動物用アレルギーと呼吸器薬
抗感染症薬
コンパニオンアニマル：細菌感染症
生産動物：細菌感染症
動物医薬品市場の主要企業
動物抗感染症薬
抗炎症薬・鎮痛薬
動物抗炎症鎮痛薬市場の主要企業
動物抗炎症鎮痛薬
代謝障害および内分泌障害の治療薬
代謝疾患と内分泌疾患
動物代謝および内分泌市場の主要企業
動物代謝薬
寄生虫駆除剤
コンパニオンアニマル：寄生虫病
生産動物：寄生虫病の例
動物寄生虫駆除剤市場の主要企業
動物寄生虫駆除剤
向精神薬
動物向精神薬市場の主要企業
自然療法
動物向精神薬
その他の医薬品
コンパニオンアニマル-その他の病気
その他の動物医薬品市場の主要企業
歯科
その他の動物医薬品

第8章世界の飼料添加剤市場

概要
飼料添加剤
コンパニオンアニマルと生産動物の市場規模
地域別の飼料添加剤市場
飼料添加剤市場の主要企業
アミノ酸
動物用アミノ酸市場の主要企業
動物用アミノ酸
医薬添加剤
動物医薬添加剤市場の主要企業
薬用飼料添加剤
栄養補助食品
動物栄養補助食品市場の主要企業
栄養補助食品市場の分析
ビタミン・ミネラル
動物用ビタミンおよびミネラル市場の主要企業
動物用ビタミンおよびミネラル

第9章世界の動物診断薬市場

概要
動物診断
コンパニオンアニマル市場と生産動物市場
地域別の動物診断薬市場
診断検査：概要
集中型および分散型臨床検査
画像診断
動物診断市場の主要企業
動物診断薬市場：製品別
迅速診断検査
診断アナライザーと消耗品
画像診断装置

第10章世界の動物治療薬および診断薬市場：地域別

北米
欧州
アジア太平洋
その他の地域

第11章 ESGの展開

ESGの概要
動物治療薬および診断薬業界におけるESGの重要性
動物治療薬および診断薬業界における主要なESG上の問題
ESG評価と指標：データの理解
動物治療薬および診断薬業界におけるESGの実践
今後の動向
BCCによる見解

第12章 M&A・資金調達の分析

M&A分析
動物ヘルスケア業界への資金提供

第13章競合情報

2022年の主要企業
企業の主要採用戦略
M&A
新製品の発売
提携
承認
その他

第14章企業プロファイル

ARKO LABORATORIES
AVIMEX
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CEVA SANTE ANIMALE (CEVA)
DECHRA PHARMACEUTICALS PLC
DSM NUTRITIONAL PRODUCTS
ELANCO ANIMAL HEALTH INC.
MERCK & CO. INC.
PHIBRO ANIMAL HEALTH CORP.
VIRBAC S.A.
ZOETIS INC.

図表

List of Tables

Summary Table : Global Market for Animal Therapeutics and Diagnostics, by Product Type, Through 2028
Table 1 : Gestation Periods of Selected Common Species
Table 2 : Lifespan of Common Species of Birds
Table 3 : Population of Food Production Animals in the United States, 2022
Table 4 : Top Broiler-Producing States in the U.S., 2021
Table 5 : Commercial Red Meat Production in the U.S., April 2022
Table 6 : Beef and Veal Consumption, by Country, Through 2025
Table 7 : Pork Consumption, by Country, Through 2025
Table 8 : Poultry Consumption, by Country, Through 2025
Table 9 : Lamb/Mutton Consumption, by Country, Through 2025
Table 10 : Dog Ownership, by Select Country, 2023
Table 11 : Cat Ownership, by Select Country, 2021
Table 12 : Horse (Equine) Population, by Country, 2023
Table 13 : Cattle (Bovine) Population, by Country, 2023
Table 14 : Pig/Hog (Swine) Population, by Country, 2021
Table 15 : Sheep Population, by Country, 2023
Table 16 : Goat Population, by Country, 2021
Table 17 : Chicken Meat Production, by Country, 2022
Table 18 : Market Dynamics: Impact Analysis
Table 19 : Number of Outbreaks, Cases and Animal Losses Caused by ASF, 2021
Table 20 : States with the Highest Employment Level in Veterinary Assistants and Laboratory Animal Caretakers, May 2022
Table 21 : Estimated Number of U.S. Private Veterinary Practices, by Type of Practice, 2021 and 2022
Table 22 : Basic Annual Spending on Pets in the U.S., APPA National Pet Owners Survey, 2022
Table 23 : Pet Insurance Plan Comparisons in the United States
Table 24 : Common Examples of Zoonotic Diseases
Table 25 : Affected Pioneer, Generic and Combination Antimicrobials Used in the U.S. Food-Producing Animals (Updated April 1, 2019)
Table 26 : Global Market for Animal Therapeutics and Diagnostics, by Product Segment, Through 2028
Table 27 : Global Market for Animal Therapeutics and Diagnostics, by Animal Group, Through 2028
Table 28 : Global Market for Animal Therapeutics and Diagnostics, by Region, Through 2028
Table 29 : Global Market for Animal Vaccines, by Animal Group, Through 2028
Table 30 : Global Market for Animal Vaccines, by Region, Through 2028
Table 31 : Global Market for Companion Animal Vaccines, by Animal Species, Through 2028
Table 32 : Boehringer Ingelheim's Companion Animal Vaccines, by Target Species
Table 33 : Elanco's Companion Animal Vaccines, by Target Species
Table 34 : Merck's Companion Animal Vaccines, by Target Species
Table 35 : Zoetis' Companion Animal Vaccines, by Target Species
Table 36 : CSF-Free Countries, OIE Member Countries, as of May 2023
Table 37 : Global Market for Production Animal Vaccines, by Animal Species, Through 2028
Table 38 : Bayer's Production Animal Vaccines, by Target Species
Table 39 : Boehringer Ingelheim's Production Animal Vaccines, by Target Species
Table 40 : Elanco's Production Animal Vaccines, by Target Species
Table 41 : Merck's Production Animal Vaccines, by Target Species
Table 42 : Zoetis' Production Animal Vaccines, by Target Species
Table 43 : Global Market for Animal Pharmaceuticals, by Type, Through 2028
Table 44 : Global Market for Animal Pharmaceuticals, by Animal Group, Through 2028
Table 45 : Global Market for Animal Pharmaceuticals, by Region, Through 2028
Table 46 : Boehringer Ingelheim's Allergy and Respiratory Drugs, by Target Species
Table 47 : Dechra Pharmaceuticals' Allergy and Respiratory Drugs, by Target Species
Table 48 : Elanco's Allergy and Respiratory Drugs, by Target Species
Table 49 : Heska's Allergy and Respiratory Drugs, by Target Species
Table 50 : Huvepharma's Allergy and Respiratory Drugs, by Target Species
Table 51 : Virbac's Allergy and Respiratory Drugs, by Target Species
Table 52 : Zoetis' Allergy and Respiratory Drugs, by Target Species
Table 53 : Global Market for Allergy and Respiratory Drugs, by Animal Group, Through 2028
Table 54 : Bayer's Anti-infective Drugs, by Target Species
Table 55 : Boehringer Ingelheim's Anti-infective Drugs, by Target Species
Table 56 : Dechra Pharmaceuticals' Anti-infective Drugs, by Target Species
Table 57 : ECO Animal Health's Anti-infective Drugs, by Target Species
Table 58 : Elanco's Anti-infective Drugs, by Target Species
Table 59 : Merck's Anti-infective Drugs, by Target Species
Table 60 : Virbac's Anti-infective Drugs, by Target Species
Table 61 : Zoetis' Anti-infective Drugs, by Target Species
Table 62 : Global Market for Anti-infectives, by Animal Group, Through 2028
Table 63 : Aratana Therapeutics' Anti-inflammatories and Analgesics, by Target Species
Table 64 : Bayer Anti-inflammatories and Analgesics, by Target Species
Table 65 : Boehringer Ingelheim's Anti-inflammatories and Analgesics, by Target Species
Table 66 : Dechra Pharmaceuticals' Anti-inflammatories and Analgesics, by Target Species
Table 67 : Elanco's Anti-inflammatories and Analgesics, by Target Species
Table 68 : Merck's Anti-inflammatories and Analgesics, by Target Species
Table 69 : Vetoquinol's Anti-inflammatories and Analgesics, by Target Species
Table 70 : Zoetis' Anti-inflammatories and Analgesics, by Target Species
Table 71 : Global Market for Anti-inflammatories and Analgesics, by Animal Group, Through 2028
Table 72 : Aratana Therapeutics' Metabolic and Endocrine Drugs, by Target Species
Table 73 : Bayer's Metabolic and Endocrine Drugs, by Target Species
Table 74 : Boehringer Ingelheim's Metabolic and Endocrine Drugs, by Target Species
Table 75 : Dechra Pharmaceuticals' Metabolic and Endocrine Drugs, by Target Species
Table 76 : Merck's Metabolic and Endocrine Drugs, by Target Species
Table 77 : Virbac's Metabolic and Endocrine Drugs, by Target Species
Table 78 : Zoetis' Metabolic and Endocrine Drugs, by Target Species
Table 79 : Global Market for Metabolic Drugs, by Animal Group, Through 2028
Table 80 : Bayer's Parasiticides, by Target Species
Table 81 : Beaphar's Parasiticides, by Target Species
Table 82 : Boehringer Ingelheim's Parasiticides, by Target Species
Table 83 : ECO Animal Health's Parasiticides, by Target Species
Table 84 : Elanco's Parasiticides, by Target Species
Table 85 : Huvepharma Parasiticides, by Target Species
Table 86 : Merck's Parasiticides, by Target Species
Table 87 : Virbac's Parasiticides, by Target Species
Table 88 : Zoetis' Parasiticides, by Target Species
Table 89 : Global Market for Parasiticides, by Animal Group, Through 2028
Table 90 : Boehringer Ingelheim's Psychotropic Medications, by Target Species
Table 91 : Elanco's Psychotropic Medications, by Target Species
Table 92 : Vetoquinol's Psychotropic Medications, by Target Species
Table 93 : Zoetis' Psychotropic Medications, by Target Species
Table 94 : Bayer's Other Pharmaceuticals, by Target Species
Table 95 : Boehringer Ingelheim's Other Pharmaceuticals, by Target Species
Table 96 : Dechra Pharmaceuticals' Other Pharmaceuticals, by Target Species
Table 97 : Elanco's Other Pharmaceuticals, by Target Species
Table 98 : HbO2 Therapeutics' Other Pharmaceuticals, by Target Species
Table 99 : Merck's Other Pharmaceuticals, by Target Species
Table 100 : Virbac's Other Pharmaceuticals, by Target Species
Table 101 : Vetoquinol's Other Pharmaceuticals, by Target Species
Table 102 : Zoetis' Other Pharmaceuticals, by Target Species
Table 103 : Dental Pharmaceuticals, by Target Species and Provider
Table 104 : Global Market for Other Pharmaceuticals, by Animal Group, Through 2028
Table 105 : Global Market for Animal Feed Additive Products, by Type, Through 2028
Table 106 : Global Market for Feed Additives, by Animal Group, Through 2028
Table 107 : Global Market for Animal Feed Additives, by Region, Through 2028
Table 108 : Adisseo's Amino Acids, by Target Species
Table 109 : Ajinomoto's Amino Acids, by Target Species
Table 110 : Boehringer Ingelheim's Amino Acids, by Target Species
Table 111 : Evonik's Amino Acids, by Target Species
Table 112 : Global Market for Amino Acids, by Animal Group, Through 2028
Table 113 : Dechra Pharmaceuticals' Medicinal Additives, by Target Species
Table 114 : ECO Animal Health Medicinal Additives, by Target Species
Table 115 : Elanco's Medicinal Additives, by Target Species
Table 116 : Huvepharma's Medicinal Additives, by Target Species
Table 117 : Merck's Medicinal Additives, by Target Species
Table 118 : Phibro's Medicinal Additives, by Target Species
Table 119 : Zoetis' Medicinal Additives, by Target Species
Table 120 : Global Market for Medicinal Feed Additives, by Animal Group, Through 2028
Table 121 : Adisseo (Bluestar) Nutritional Supplements, by Target Species
Table 122 : Bayer's Nutritional Supplements, by Target Species
Table 123 : BASF's Nutritional Supplements, by Target Species
Table 124 : Beaphar's Nutritional Supplements, by Target Species
Table 125 : Boehringer Ingelheim's Nutritional Supplements, by Target Species
Table 126 : Dechra Pharmaceuticals' Nutritional Supplements, by Target Species
Table 127 : DSM's Nutritional Supplements, by Target Species
Table 128 : Elanco's Nutritional Supplements, by Target Species
Table 129 : Evonik's Nutritional Supplements, by Target Species
Table 130 : Heska's Nutritional Supplements, by Target Species
Table 131 : Mosaic's Nutritional Supplements, by Target Species
Table 132 : Vetoquinol's Nutritional Supplements, by Target Species
Table 133 : Virbac's Nutritional Supplements, by Target Species
Table 134 : Global Market for Nutritional Supplements, by Animal Group, Through 2028
Table 135 : Adisseo's Vitamins and Minerals, by Target Species
Table 136 : BASF's Vitamins and Minerals, by Target Species
Table 137 : Bayer's Vitamins and Minerals, by Target Species
Table 138 : Beaphar's Vitamins and Minerals, by Target Species
Table 139 : DSM's Vitamins and Minerals, by Target Species
Table 140 : Merck's Vitamins and Minerals, by Target Species
Table 141 : Zoetis' Vitamins and Minerals, by Target Species
Table 142 : Global Market for Vitamins and Minerals, by Animal Group, Through 2028
Table 143 : Global Market for Animal Diagnostics, by Type, Through 2028
Table 144 : Global Market for Animal Diagnostic Products, by Animal Group, Through 2028
Table 145 : Global Market for Animal Diagnostics, by Region, Through 2028
Table 146 : Bayer's Diagnostics, by Target Species
Table 147 : Beaphar's Diagnostics, by Target Species
Table 148 : Elanco's Diagnostics, by Target Species
Table 149 : Heska's Diagnostics, by Target Species
Table 150 : IDEXX's Diagnostics, by Target Species
Table 151 : Merck's Diagnostics, by Target Species
Table 152 : Virbac's Diagnostics, by Target Species
Table 153 : Zoetis' Diagnostics, by Target Species
Table 154 : Global Market for Rapid Diagnostics Tests, by Animal Group, Through 2028
Table 155 : Global Market for Diagnostic Analyzers and Consumables, by Animal Group, Through 2028
Table 156 : Global Market for Diagnostic Imaging Equipment and Related Materials, by Animal Group, Through 2028
Table 157 : Global Market for Animal Therapeutics and Diagnostics, by Region, Through 2028
Table 158 : ESG Ratings and Metrics
Table 159 : Environmental Performance: Animal Therapeutics and Diagnostics Industry
Table 160 : Social Performance: Animal Therapeutics and Diagnostics Industry
Table 161 : Governance Performance: Animal Therapeutics and Diagnostics Industry
Table 162 : ESG Rankings for Major Animal Therapeutics and Diagnostics Companies, March 2023
Table 163 : M&A in the Animal Healthcare Industry, 2021
Table 164 : Mergers & Acquisitions: Market for Animal Therapeutics and Diagnostics, August 2020-December 2022
Table 165 : New Product Launches: Market for Animal Therapeutics and Diagnostics, March 2022-November 2022
Table 166 : Partnerships: Market for Animal Therapeutics and Diagnostics, March 2021-March 2023
Table 167 : Partnerships: Market for Animal Therapeutics and Diagnostics, March 2021-March 2023
Table 168 : Others: Market for Animal Therapeutics and Diagnostics, November 2021-June 2023
Table 169 : ARKO Laboratories: Animal Health Products
Table 170 : Avimex: Animal Vaccine Products
Table 171 : Avimex: News, 2021
Table 172 : Boehringer Ingelheim: Key Financials, 2022
Table 173 : Boehringer Ingelheim: News, 2022 and 2023
Table 174 : Boehringer Ingelheim: Animal Health Products
Table 175 : Ceva: Key Financials, 2022
Table 176 : Ceva: News, 2022 and 2023
Table 177 : Ceva: Animal Health Products
Table 178 : Dechra: Key Financials, 2022
Table 179 : Dechra: News, 2021-2023
Table 180 : Dechra: Animal Health Products
Table 181 : DSM Nutritional Products: Key Financials, 2022
Table 182 : DSM Nutritional Products: News, 2022
Table 183 : DSM Nutritional Products Ltd: Animal Health Products
Table 184 : Elanco: Key Financials, 2022
Table 185 : Elanco: News, 2020-2023
Table 186 : Elanco: Animal Health Products
Table 187 : Merck & Co. Inc.: Key Financials, 2022
Table 188 : Merck & Co. Inc.: News, 2022
Table 189 : Merck & Co. Inc.: Animal Health Products
Table 190 : Phibro Animal Health Corp.: Key Financials, 2022
Table 191 : Phibro Animal Health Corp.: News, 2022
Table 192 : Phibro Animal Health Corp.: Animal Vaccine Products
Table 193 : Virbac S.A.: Key Financials, 2022
Table 194 : Virbac S.A.: News, 2021 and 2022
Table 195 : Virbac S.A.: Animal Vaccine Products
Table 196 : Zoetis Services LLC: Key Financials, 2022
Table 197 : Zoetis Services LLC: News, 2021-2023
Table 198 : Zoetis Services LLC : Animal Vaccine Products

List of Figures

Summary Figure : Global Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
Figure 1 : Number of Countries Affected by HPAI, 2005-2021
Figure 2 : Modalities for Purchasing Rabies Vaccine from World Vaccine Bank, 2012-2021
Figure 3 : Worldwide Distribution of SARS-CoV-2 Outbreaks in 23 Animal Species
Figure 4 : Global Market for Animal Therapeutics and Diagnostics, by Product Segment, 2020-2028
Figure 5 : Global Market for Animal Therapeutics and Diagnostics, by Animal Group, 2020-2028
Figure 6 : Global Market for Animal Therapeutics and Diagnostics, by Region, 2020-2028
Figure 7 : Global Market for Animal Vaccines, by Animal Group, 2020-2028
Figure 8 : Global Market for Animal Vaccines, by Region, 2020-2028
Figure 9 : Global Market Shares of Animal Vaccines, by Region, 2023
Figure 10 : Global Market for Companion Animal Vaccines, by Animal Species, 2020-2028
Figure 11 : Global Market for Companion Animal Vaccines, by Type, 2020-2028
Figure 12 : Global Market for Production Animal Vaccines, by Animal Species, 2020-2028
Figure 13 : Global Market for Production Animal Vaccines, by Type, 2020-2028
Figure 14 : Global Market for Animal Pharmaceuticals, by Type, 2020-2028
Figure 15 : Global Market Shares of Animal Pharmaceuticals, by Animal Group, 2023
Figure 16 : Global Market Shares of Animal Pharmaceuticals, by Region, 2023
Figure 17 : Global Market for Allergy and Respiratory Drugs, by Animal Group, 2020-2028
Figure 18 : Global Market for Anti-infectives, by Animal Group, 2020-2028
Figure 19 : Global Market for Anti-inflammatories and Analgesics, by Animal Group, 2020-2028
Figure 20 : Global Market for Metabolic Drugs, by Animal Group, 2020-2028
Figure 21 : Global Market for Parasiticides, by Animal Group, 2020-2028
Figure 22 : Global Market for Other Pharmaceuticals, by Animal Group, 2020-2028
Figure 23 : Global Market for Animal Feed Additive Products, by Type, 2020-2028
Figure 24 : Global Market Shares of Feed Additives, by Animal Group, 2023
Figure 25 : Global Market Shares of Animal Feed Additives, by Region, 2023
Figure 26 : Global Market for Amino Acids, by Animal Group, 2020-2028
Figure 27 : Global Market for Medicinal Feed Additives, by Animal Group, 2020-2028
Figure 28 : Global Market for Nutritional Supplements, by Animal Group, 2020-2028
Figure 29 : Global Market for Vitamins and Minerals, by Animal Group, 2020-2028
Figure 30 : Global Market for Animal Diagnostics, by Type, 2020-2028
Figure 31 : Global Market Shares of Animal Diagnostics, by Animal Group, 2023
Figure 32 : Global Market Shares of Animal Diagnostics, by Region, 2023
Figure 33 : Global Market for Rapid Diagnostic Tests, by Animal Group, 2020-2028
Figure 34 : Global Market for Rapid Diagnostics, by Test Type (Veterinary Applications), 2020-2028
Figure 35 : Global Market for Diagnostic Analyzers and Consumables, by Animal Group, 2020-2028
Figure 36 : Global Market for Diagnostic Analyzers and Consumables, by Test Type (Veterinary Applications), 2020-2028
Figure 37 : Global Market for Diagnostic Imaging Equipment and Related Materials, by Animal Group, 2020-2028
Figure 38 : Global Market Shares of Animal Therapeutics and Diagnostics, by Region, 2023
Figure 39 : North American Beef Cattle Inventory, 2000-2022
Figure 40 : North American Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
Figure 41 : European Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
Figure 42 : Asia-Pacific Market for Animal Therapeutics and Diagnostics, by Product Type, 2020-2028
Figure 43 : Rest of the World Market for Animal Therapeutics and Diagnostics, by Product Type, 2022-2028
Figure 44 : How A Strong ESG Proposition Benefits Businesses
Figure 45 : The Ten Business Sustainability Trends Identified for 2022
Figure 46 : Top Animal Health Mergers and Acquisitions Worldwide, 2014-2018, by Enterprise Value
Figure 47 : Animal Healthcare Industry: M & A Deals, 2019-2021
Figure 48 : Leading Market Players' Animal Health Revenue, 2022
Figure 49 : Global Market Shares of Animal Therapeutics and Diagnostics: Competitive Intelligence, 2020 to 2023
Figure 50 : Boehringer Ingelheim: Key Financials, 2021 and 2022
Figure 51 : Boehringer Ingelheim: Revenue Share, by Business Unit, 2022
Figure 52 : Boehringer Ingelheim: Revenue Share, by Region, 2022
Figure 53 : Ceva: Key Financials, 2021 and 2022
Figure 54 : Dechra: Key Financials, 2021 and 2022
Figure 55 : Dechra: Revenue Share, by Business Unit, 2022
Figure 56 : Dechra: Revenue Share, by Region, 2022
Figure 57 : DSM Nutritional Products: Key Financials, 2021 and 2022
Figure 58 : DSM Nutritional Products Ltd: Revenue Share, by Business Unit, 2022
Figure 59 : DSM Nutritional Products Ltd: Revenue Share, by Country/Region, 2022
Figure 60 : Elanco: Key Financials, 2021 and 2022
Figure 61 : Elanco: Revenue Share, by Business Unit, 2022
Figure 62 : Elanco: Revenue Share, by Country/Region, 2022
Figure 63 : Merck & Co. Inc.: Key Financials, 2021 and 2022
Figure 64 : Merck & Co. Inc.: Revenue Share, by Business Unit, 2022
Figure 65 : Merck & Co. Inc.: Revenue Share, by Country/Region, 2022
Figure 66 : Phibro Animal Health Corp.: Key Financials, 2021 and 2022
Figure 67 : Phibro Animal Health Corp.: Revenue Share, by Business Unit, 2022
Figure 68 : Phibro Animal Health Corp.: Revenue Share, by Country/Region, 2022
Figure 69 : Virbac S.A.: Key Financials, 2021 and 2022
Figure 70 : Virbac S.A.: Revenue Share, by Business Unit, 2022
Figure 71 : Zoetis Services LLC: Key Financials, 2021 and 2022
Figure 72 : Zoetis Services LLC : Revenue Share, by Business Unit, 2022
Figure 73 : Zoetis Services LLC: Revenue Share, by Country/Region, 2022

Product Code: HLC034G

Highlights:

The global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.

The global market for animal therapeutics and diagnostics for pharmaceuticals segment is estimated to increase from $24.6 billion in 2023 to reach $33.3 billion by 2028, at a compound annual growth rate (CAGR) of 6.2% from 2023 through 2028.

The global market for animal therapeutics and diagnostics for feed additives segment is estimated to increase from $21.6 billion in 2023 to reach $27.5 billion by 2028, at a compound annual growth rate (CAGR) of 5.0% from 2023 through 2028.

##img_0##

Report Scope:

The report's scope includes an overview of the global market for animal therapeutics and diagnostics along with an analysis of global market trends; the report uses 2022 as the base year and forecasts 2023 the compound annual growth rate (CAGR) for 2023 to 2028.

The report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends, and statistics by key geographical regions such as the United States, European countries, and Brazil, Japan, and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers, and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.

Report Includes:

56 data tables and 143 additional tables
An overview of the global market for animal therapeutics and diagnostics
Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
Assessment of market drivers, opportunities, and restraints, and current trends and technological advances
Evaluation of the market with a focus of global production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs
Analyses of the market shares of the leading suppliers of animal vaccines and therapeutic drugs, the competitive landscape, market positioning, revenue sales and product segments
Discussion of the role of major providers of vaccines and companion animal products approved for a wide variety of indications, and emerging technologies in the market.
Analyses of ESG trends and patents granted for animal health products
Profiles of the leading companies, including Boehringer Ingelheim, DSM Nutritional Products, Merck & Co. Inc., Phibro Animal Health Corp., Virbac S.A., and Zoetis Services LLC

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Report
Research Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights

Market Outlook
Market Summary
Trends Driving the Animal Health Industry

Chapter 3 Market Overview

Animal Anatomy and Physiology
Reproductive System
Avian Anatomy
Animal Populations in the United States
Companion Animals
Food Production Animals
Meat Consumption
Animal Populations by Country

Chapter 4 Market Dynamics

Market Dynamics
Drivers
Market Restraints
Opportunities
Regulatory Landscape
Food and Drug Administration (FDA)
European Medicines Agency (EMA) and Committee for Medicinal Products for Veterinary Use (CVMP)
Australian Pesticides and Veterinary Medicines Authority (APVMA)
The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil
Antibiotic Use and Resistance in Production Animals
FDA's Antimicrobial Restrictions
Levels of Contaminated Meats in the U.S.
Movement for Lower Amounts of Antibiotics in Livestock Production
Minimally and Highly Regulated Products
Animal Drug User Fee Act of 2003
Animal Drug User Fee Amendments of 2008 (ADUFA II)
Animal Drug User Fee Amendments of 2013 (ADUFA III)
Animal Drug User Fee Amendments of 2018 (ADUFA III)

Chapter 5 Global Market for Animal Therapeutics and Diagnostics

Overview
Market Size

Chapter 6 Global Market for Animal Vaccines

Overview
Product Introduction
Active Immunity
Passive Immunity
Other Types
Companion Animals
Viruses
Companion Animal Vaccines
Major Players in the Market for Companion Animal Vaccines
Vaccine Providers
Production Animals
Viruses and Prions
Production Animal Vaccines
Major Players in the Market for Production Animal Vaccines

Chapter 7 Global Market for Animal Pharmaceuticals

Overview
Animal Pharmaceuticals
Companion Animal vs. Production Animal Markets
Animal Pharmaceuticals Market by Region
Allergy and Respiratory Drugs
Companion Animals: Allergy and Inflammatory Diseases
Major Players in the Market for Animal Allergy and Respiratory Drugs
Animal Allergy and Respiratory Drugs
Anti-infectives
Companion Animals-Bacterial Infections
Production Animals-Bacterial Infections
Major Players in the Market for Animal Drugs
Animal Anti-infectives
Anti-inflammatories and Analgesics
Major Players in the Market for Animal Anti-Inflammatory and Analgesic Drugs
Animal Anti-Inflammatory and Analgesic Drugs
Metabolic and Endocrine Disorder Drugs
Metabolic Diseases and Endocrine Disorders
Major Players in the Market for Animal Metabolic and Endocrines
Animal Metabolic Drugs
Parasiticides
Companion Animals-Parasitic Diseases
Production Animals-Parasitic Disease Example
Major Players in the Market for Animal Parasiticides
Animal Parasiticides
Psychotropic Medications
Major Players in the Market for Animal Psychotropic Medications
Natural Remedies
Animal Psychotropic Medications
Other Pharmaceuticals
Companion Animals-Other Diseases
Major Players in Market for Other Animal Pharmaceuticals
Dental
Other Animal Pharmaceuticals

Chapter 8 Global Market for Animal Feed Additives

Overview
Animal Feed Additives
Companion Animal vs. Production Animal Market Size
Market for Animal Feed Additives by Region
Major Players in the Market for Animal Feed Additives
Amino Acids
Major Players in the Market for Amino Acids for Animals
Amino Acids for Animals
Medicinal Additives
Major Players in the Market for Medicinal Additives for Animals
Medicinal Feed Additives
Nutritional Supplements
Major Players in the Market for Animal Nutritional Supplements
Nutritional Supplement Market Analysis
Vitamins and Minerals
Major Players in the Market for Vitamins and Minerals for Animals
Vitamins and Minerals for Animals

Chapter 9 Global Market for Animal Diagnostics

Overview
Animal Diagnostics
Companion Animal vs. Production Animal Markets
Market for Animal Diagnostics by Region
Diagnostic Test Descriptions
Centralized and Decentralized Laboratory Tests
Diagnostic Imaging
Major Players in the Market for Animal Diagnostics
Market for Animal Diagnostics by Product
Diagnostic Rapid Testing
Diagnostic Analyzers and Consumables
Diagnostic Imaging Equipment

Chapter 10 Global Market for Animal Therapeutics and Diagnostics by Region

North America
Europe
Asia-Pacific
Rest of the World

Chapter 11 ESG Developments

Introduction to ESG
Importance of ESG in the Animal Therapeutics and Diagnostics Industry
Key ESG Issues in the Animal Therapeutics and Diagnostics Industry
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Animal Therapeutics and Diagnostics Industry
Future Trends
BCC Research Viewpoint

Chapter 12 M&A and Funding Analysis

M&A Analysis
Funding in the Animal Healthcare Industry

Chapter 13 Competitive Intelligence

Top Market Players 2022
Key Strategies Adopted by Companies
Mergers & Acquisitions
New Product Launches
Partnerships
Approvals
Others

Chapter 14 Company Profiles

ARKO LABORATORIES
AVIMEX
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CEVA SANTE ANIMALE (CEVA)
DECHRA PHARMACEUTICALS PLC
DSM NUTRITIONAL PRODUCTS
ELANCO ANIMAL HEALTH INC.
MERCK & CO. INC.
PHIBRO ANIMAL HEALTH CORP.
VIRBAC S.A.
ZOETIS INC.

動物治療薬および診断薬の世界市場

Global Markets for Animal Therapeutics and Diagnostics

目次

第1章イントロダクション

第2章サマリー・ハイライト

第3章市場概要

第4章市場力学

第5章世界の動物治療薬および診断薬市場

第6章世界の動物ワクチン市場

第7章世界の動物医薬品市場

第8章世界の飼料添加剤市場

第9章世界の動物診断薬市場

第10章世界の動物治療薬および診断薬市場：地域別

第11章 ESGの展開

第12章 M&A・資金調達の分析

第13章競合情報

第14章企業プロファイル

List of Tables

List of Figures

Highlights:

Report Scope:

Report Includes:

Table of Contents

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Global Market for Animal Therapeutics and Diagnostics

Chapter 6 Global Market for Animal Vaccines

Chapter 7 Global Market for Animal Pharmaceuticals

Chapter 8 Global Market for Animal Feed Additives

Chapter 9 Global Market for Animal Diagnostics

Chapter 10 Global Market for Animal Therapeutics and Diagnostics by Region

Chapter 11 ESG Developments

Chapter 12 M&A and Funding Analysis

Chapter 13 Competitive Intelligence

Chapter 14 Company Profiles

動物治療薬および診断薬の世界市場

Global Markets for Animal Therapeutics and Diagnostics

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

第4章 市場力学

第5章 世界の動物治療薬および診断薬市場

第6章 世界の動物ワクチン市場

第7章 世界の動物医薬品市場

第8章 世界の飼料添加剤市場

第9章 世界の動物診断薬市場

第10章 世界の動物治療薬および診断薬市場：地域別

第11章 ESGの展開

第12章 M&A・資金調達の分析

第13章 競合情報

第14章 企業プロファイル

List of Tables

List of Figures

Highlights:

Report Scope:

Report Includes:

Table of Contents

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Global Market for Animal Therapeutics and Diagnostics

Chapter 6 Global Market for Animal Vaccines

Chapter 7 Global Market for Animal Pharmaceuticals

Chapter 8 Global Market for Animal Feed Additives

Chapter 9 Global Market for Animal Diagnostics

Chapter 10 Global Market for Animal Therapeutics and Diagnostics by Region

Chapter 11 ESG Developments

Chapter 12 M&A and Funding Analysis

Chapter 13 Competitive Intelligence

Chapter 14 Company Profiles

第1章イントロダクション

第2章サマリー・ハイライト

第3章市場概要

第4章市場力学

第5章世界の動物治療薬および診断薬市場

第6章世界の動物ワクチン市場

第7章世界の動物医薬品市場

第8章世界の飼料添加剤市場

第9章世界の動物診断薬市場

第10章世界の動物治療薬および診断薬市場：地域別

第13章競合情報

第14章企業プロファイル